Mobocertinib in Platinum-Pretreated EGFR Exon 20 Insertion+ Metastatic NSCLC Patients With/Without Prior Anti-PD(L)-1 Therapy Meeting Abstract

Industry Collaboration International Collaboration

cited authors

  • Janne, P.; Ramalingam, S.; Kim, T.; Yang, J. C.; Riely, G.; Mekhail, T.; Nguyen, D.; Garcia Campelo, M. R.; Felip, E.; Jin, S.; Griffin, C.; Bunn, V.; Lin, J.; Mehta, M.; Zhou, C.

authors

Publication Date

  • October 1, 2021

webpage

published in

category

keywords

  • EGFR tyrosine kinase inhibitor
  • exon20 insertion
  • non-small cell lung cancer

start page

  • S960

end page

  • S960

volume

  • 16

issue

  • 10